Retatrutide 20mg

Retatrutide (GLP-1/GIP/Glucagon Triple Agonist)

Retatrutide is a next-generation triple receptor agonist that simultaneously targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-receptor approach represents one of the most advanced peptide compounds currently under clinical investigation for metabolic research.

Key Features

• Triple Agonist Activity: Activates GLP-1, GIP, and glucagon receptors simultaneously for a comprehensive metabolic effect profile
• High Purity: ≥99% purity verified by HPLC and Mass Spectrometry
• Lyophilized Powder: Stable, research-grade formulation for extended shelf life
• Quantity: 10mg per vial

Research Applications

Retatrutide is intended strictly for laboratory and in-vitro research purposes. It is not approved for human or veterinary use. Researchers studying metabolic pathways, energy homeostasis, and receptor pharmacology will find this compound of significant interest.

Storage & Handling

• Store lyophilized peptide at -20°C
• Protect from light and moisture
• Reconstitute with bacteriostatic water prior to use
• Use within 28 days of reconstitution when stored at 4°C

For research use only. Not for human consumption. Must be handled by qualified professionals in a controlled laboratory environment.